Table 3.
Characteristic | Without PCR* Testing | With PCR* Testing | P-value |
---|---|---|---|
Number cases | 98 | 25 | |
Demographics | |||
Age, median, years (25th 75th percentile) | 66 (56, 74) | 55 (50, 70) | 0.07 |
Age category, years (%) | 0.13 | ||
≤16 | 2 | 0 | |
17–50 | 12 | 24 | |
51–60 | 25 | 32 | |
>60 | 61 | 44 | |
Gender (%) | 0.16 | ||
Men | 37 | 52 | |
Women | 63 | 48 | |
Race/ethnicity (%) | 0.01 | ||
White, non-Hispanic | 81 | 52 | |
Black, non-Hispanic | 3 | 4 | |
Hispanic | 3 | 0 | |
Asian, Pacific Islander | 10 | 20 | |
Other | 1 | 8 | |
Missing/unknown | 2 | 16 | |
Uveitis History | |||
Uveitis course (%) | 0.62 | ||
Acute, monophasic | 34 | 46 | |
Acute, recurrent | 5 | 8 | |
Chronic | 42 | 38 | |
Indeterminate | 18 | 8 | |
Laterality (%) | 0.91 | ||
Unilateral | 96 | 96 | |
Bilateral | 4 | 4 | |
Ophthalmic examination | |||
Cornea | 0.74 | ||
No keratitis | 71 | 68 | |
Keratitis | 29 | 32 | |
Keratic precipitates (%) | 0.63 | ||
None | 31 | 28 | |
Fine | 44 | 36 | |
Round | 9 | 16 | |
Stellate | 4 | 0 | |
Mutton Fat | 11 | 20 | |
Other | 1 | 0 | |
Anterior chamber cells (%) | 0.33 | ||
Grade ½+ | 32 | 8 | |
1+ | 37 | 16 | |
2+ | 23 | 48 | |
3+ | 4 | 20 | |
Anterior chamber flare (%) | 0.76 | ||
Grade 0 | 54 | 60 | |
1+ | 36 | 28 | |
2+ | 10 | 12 | |
Iris (%) | |||
Normal | 83 | 64 | 0.06 |
Posterior synechiae | 6 | 8 | 0.66 |
Sectoral iris atrophy | 9 | 16 | 0.25 |
Other iris abnormality | 6 | 24 | 0.001 |
Intraocular pressure (IOP), involved eyes | |||
Median, mm Hg (25th, 75th percentile) | 15 (12, 20) | 16 (14, 30) | 0.12 |
Percent patients with IOP>24 mm Hg either eye | 21 | 36 | 0.29 |
Vitreous cells (%) | 0.08 | ||
Grade 0 | 89 | 84 | |
½+ | 10 | 8 | |
≥1+ | 1 | 8 | |
Immune compromised host (%) | 8 | 5 | 0.22 |
Dermatomal Herpes zoster (%) | 98 | 40 | <0.0001 |
PCR = polymerase chain reaction; testing for varicella zoster virus in aqueous.